New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher risk of being hospitalised and dying from COVID-19 than the general population.
Psychedelic Therapy: Empowering Ukraine’s Mental Health Frontlines
The TDR Three Key Takeaways for psychedelic therapy training in the Ukraine: Fluence’s partnership with UPRA and HUT offers free psychedelic therapy training to Ukrainian